Phibro Animal Health Corp. engages in the manufacture of animal health and mineral nutrition products. It operates through the following business segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops, manufactures, and markets antibacterial, nutritional specialty products, and vaccines. The Mineral Nutrition segment comprises of the formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment offers production of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.
(PAHC) 非流动负债占总资产比率: 55.2% (近十二个月) Phibro Animal Health Corp.非流动负债占总资产比率为 55.2% 。 非流动负债总资产比率(Total Non Curl...财报说 财报 年报 季报 财务报表 财报分析 新手 入门 价值投资 A股 港股 美股 巴菲特 十倍股Phibro Animal Health Corp.(PAHC) 非流动负债占总资产比率(%)Phibro Animal Health Corp.(PAHC) 非流动负债占总资产比率(%)
本文链接： http://pahc.immuno-online.com/view-706944.html
